Ignite Creation Date:
2025-12-26 @ 4:03 PM
Ignite Modification Date:
2026-03-02 @ 3:43 PM
Study NCT ID:
NCT02034006
Status:
COMPLETED
Last Update Posted:
2019-02-18
First Post:
2014-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06-10
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07-15
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-09
First Submit QC Date:
None
Study First Post Date:
2014-01-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-07-11
Results First Submit QC Date:
None
Results First Post Date:
2019-02-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-08
Last Update Post Date:
2019-02-18
Last Update Post Date Type:
ACTUAL